Ticker LaunchIPO · ORIC
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. (ORIC) priced its initial public offering on Apr 24, 2020 at $16.00 per share, within its $14.00–$16.00 range, raising $120M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $460.7M. J.P. Morgan was lead-left underwriter, joined by Citigroup, Jefferies and Guggenheim. Wilson Sonsini advised the company and Cooley advised the underwriters.
- Status
- IPO
- Ticker
- ORIC
- Exchange
- Nasdaq Global Select
- Priced
- Apr 24, 2020
- IPO price
- $16.00
- Price range
- $14.00–$16.00
- Raised
- $120M
- Market cap at IPO price
- $460.7M
- First filed
- Feb 28, 2020
- Underwriters
- J.P. Morgan, Citigroup, Jefferies and Guggenheim
- Company counsel
- Wilson Sonsini
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Feb 28, 2020
- Latest amendment Apr 23, 2020
- Final prospectus (424B4) Apr 24, 2020
- All filings on EDGAR CIK 1796280
Other Biotech & pharma IPOs in 2020
- Applied Molecular Transport Inc.AMTI · Jun 5, 2020 · $154M
- Pliant Therapeutics, Inc.PLRX · Jun 3, 2020 · $144M
- ADC Therapeutics SAADCT · May 18, 2020
- Keros Therapeutics, Inc.KROS · Apr 8, 2020 · $96M
- Zentalis Pharmaceuticals, Inc.ZNTL · Apr 6, 2020 · $165.2M
- Enliven Therapeutics, Inc.IMRA · Mar 12, 2020 · $75.2M